| Stage | PTLO | % of rev | MCS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $199M | 100.00% | $238M | 100.00% | MCS ×1.20 |
| Gross profit | $129M | 65.03% | $114M | 47.79% | PTLO +17.2pp |
| Operating income | $14M | 6.92% | $30M | 12.74% | MCS +5.8pp |
| Pre-tax income | $9M | 4.49% | $28M | 11.72% | MCS +7.2pp |
| Net income | $7M | 3.60% | $19M | 7.89% | MCS +4.3pp |
| Stage | PTLO | MCS | Gap · A − B |
|---|---|---|---|
| Revenue | $199M100.00% | $238M100.00% | MCS ×1.20 |
| Gross profit | 65.03%$129M | 47.79%$114M | PTLO +17.2pp |
| Operating income | 6.92%$14M | 12.74%$30M | MCS +5.8pp |
| Pre-tax income | 4.49%$9M | 11.72%$28M | MCS +7.2pp |
| Net income |
| 3.60%$7M |
| 7.89%$19M |
| MCS +4.3pp |
No disclosed counterparties: MCS.
None